The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lymphovascular invasion as a prognostic factor in pT2 urothelial carcinoma.
 
Iván Macharashvili
Honoraria - AstraZeneca; Bayer
Speakers' Bureau - AstraZeneca; Bayer
Travel, Accommodations, Expenses - Raffo
 
Ivan Adolfo Schwartz
No Relationships to Disclose
 
Patricia Rioja
No Relationships to Disclose
 
Felipe Jové
Travel, Accommodations, Expenses - Pfizer
 
Ana Salomón
No Relationships to Disclose
 
Silvia Neciosup
No Relationships to Disclose
 
Mariano Aymar
No Relationships to Disclose
 
Mario Hernandez
No Relationships to Disclose
 
Maria Gandur-Quiroga
No Relationships to Disclose
 
Matias Gonzalez
No Relationships to Disclose
 
Daniel Castellano Gauna
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Timothy Gilligan
No Relationships to Disclose
 
Federico Cayol
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Janssen Oncology; Pfizer
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Merck KGaA; Merck Serono; Pfizer; Roche